HEALTH OF WOMAN. 2015.9(105):88–92 

The problem of leptines in gynecological endocrinology 

Dubossarska Z. M.

SI «Dnipropetrovsk medical Academy of MH of Ukraine» 

In the clinical lecture that was proposed by practical doctor, were opened modern scientific data on the importance of adipose tissue as an endocrine organ and its main hormone – leptin not only in the case of "diseases of civilization": diabetes mellitus of the second type, obesity, coronary heart disease, atherosclerotic manifestations, metabolic syndrome, but also disorders of the women`s reproductive function. Keeping patients on an interdisciplinary level, together with the endocrinologist to clarify the impact of the regulatory mechanism of leptin and how it will normalize reproductive function of women. 

Key words: obesity, leptin, insulin resistance, impaired reproductive function. 

REFERENCES

1. Аметов АС, Демидова ТЮ, Целиковская АЛ. 2001. Влияние лептина на регуляцию массы тела. Consilium medicum 2;3:20–23.

2. Давыдов АИ, Стрижаков МА, Орлов ОН. 2004. Вопросы акушерства, гинекологии и перинатологии 3;6:84–89.

3. Дедов ИИ, Мельниченко ГА, Романцова ТИ. 2004. Ожирение и метаболизм 1:3–9.

4. Дубоссарская ЗМ, Дубоссарская ЮА. 2008. Репродуктивная эндокринология (перинатальные, акушерские и гинекологические аспекты): Учебно-методическое пособие. Д, Лира ЛТД:229–238.

5. Дубоссарская ЗМ, Дука ЮМ. 2013. Принципы коррекции лепидного профиля у беременных с ожирением. Таврический медико-биологический вестник. научно-практич. журнал 15;2.–4.1(58):106–109.

6. Дубоссарська ЗМ, Дука ЮМ. 2014. Характеристика показників улеводного обміну у вагітних жінок з ожирінням. Здоровье женщины 8:39–42.

7. Прилепская ВН, Цаллагова ЕВ. 2004. Гинекологическая эндокринология. М:283–320.

8. Скибчик ВА, Скибчик ЯВ. 2007. Проблема лептинемії при серцево-судинних захворюваннях. Український медичний часопис ХІ/ХІІ;6(62):45–50.

9. Ahima RS, Flier JS. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11(8):327–332.

10. Ahren B, Larsson H, Wilhelmsson C et al. 1997. Regulation of circulating leptin in humans. Endocrine. 7(1):1–8. http://dx.doi.org/10.1007/BF02778056; PMid:9449025

11. Bouloumie A, Drexler HC, Lafontan M, Busse R. 1998. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83(10):1059–1066.

12. Bradley RL, Cleveland KA, Cheatham B. 2001. The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. Recent Prog. Horm. Res. 56:329–358. http://dx.doi.org/10.1210/rp.56.1.329; PMid:11237220

13. Brennan AM, Li TY, Kelesidis I et al. 2007. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50(6):1178–1185. http://dx.doi.org/10.1007/s00125-007-0635-y; PMid:17372717

14. Chan JL, Bluher S, Yiannakouris N et al. 2002. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51(7):2105–2112. http://dx.doi.org/10.2337/diabetes.51.7.2105; PMid:12086939

15. Chen H, Charlat O, Tartaglia LA еt al. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a muta­tion in the leptin receptor gene in db/db mice. Cell. 84(3):491–495. http://dx.doi.org/10.1016/S0092-8674(00)81294-5

16. Chu NF, Chang JB, Shieh SM. 2003. Plasma leptin, fatty acids, and tumor necrosis factor–receptor and insulin resistance in children. Obes. Res. 11(4):532–540.

17. Coleman DL. 1973. Effects of parabiosis of obese with dia­betes and normal mice. Diabetologia 9(4):294–298. http://dx.doi.org/10.1007/BF01221857; PMid:4767369

18. Coleman RA, Herrmann TS. 1999. Nutritional regulation of leptin in humans. Diabetologia 42(6):639–646. http://dx.doi.org/10.1007/s001250051210; PMid:10382582

19. Considine RV, Sinha MK, Heiman ML et al. 1996. Serum immunoreactive – leptin concentrations in normal–weight and obese humans. N. Engl. J. Med. 334(5):292–295.